Director, Strategic Initiative Management
Lawrence Township, Nj, Us
ENTERPRISE INTEGRATION MANAGEMENT OFFICE: CELGENE ACQUISITIONOperations Lead responsible for standing up the governance, processes, and systems necessary to achieve a successful 'Day 1' and the multi-year integration program leading to the successful combination of the two companies delivering value to our patients, our shareholders, and our workforce.VISION 2020: COMPANY TRANSFORMATIONWorked with Leadership Team to design & implement future state operating model. Coordinated design of commercial, R&D, manufacturing, & enabling functions in alignment with global design principles. Led Program Management Office responsible for identifying, prioritizing, planning, executing, & managing interdependent initiatives necessary to achieve future state vision. On track to deliver $1 billion cost reduction by 2020, supporting 10% increase in annual R&D spend, while significantly improving net operating margin.SPECIALTY BIOPHARMA TRANSFORMATIONEstablished and led Enterprise Program Management Office in support of specialty biopharma transformation. Operationalized operating leadership team to accelerate execution of cross-divisional initiatives. Deployed technology to increase awareness of organizational impact of simultaneous initiatives resulting in more effective phasing and minimizing business disruption. Developed and implemented capability for identification, selection, & management of a company-wide initiative portfolio.GLOBAL DIABETES BUSINESS TRANSITIONLed cross-functional BMS Transition Leadership Team comprised of 50+ resources in planning and executing the transition of $1.6B revenue, 3,500 employee, fully integrated business with operations in 50+ countries, spanning commercial, R&D, manufacturing, & enabling functions. Defined and mobilized unique PMO and Transition Services Agreement management structure & flexible processes, in collaboration with Buyer, to monitor separation progress, mitigate execution risk, & minimize business disruption.